precision drug delivery

MEQUON, Wis., July 15, 2026 Vector Science & Therapeutics has significantly expanded its intellectual property (IP) portfolio with 15...

CARY, N.C. and BRADENTON, Fla., May 20, 2026 Continuity Biosciences has announced the initiation of a Phase I first-in-human...